- BGI Genomics held its first Whole Exome Sequencing training for Southeast Asia, hosting professionals from Thailand, Indonesia, and Vietnam.
- The workshop covered hands-on variant classification, ACMG guidelines, real case studies, and high-throughput sequencing for genetic disease diagnosis.
- BGI plans continued hybrid training and regional programs to boost clinical genomics capacity and international collaboration in Southeast Asia.
BGI Genomics concluded its first Whole Exome Sequencing (WES) Interpretation of Genetic Diseases Training Workshop for Southeast Asia, a milestone in cross-cultural genomics education.
Convened at the BGI Center in late May, the week-long workshop gathered up-and-coming healthcare professionals and researchers from Thailand, Indonesia, and Vietnam for a comprehensive, hands-on training.
The initiative set out to enhance genetic disease diagnosis in Southeast Asia. It provided both classroom instruction and practical training in genetics, molecular biology, and biochemistry. They learned about the application of high-throughput sequencing technologies in clinical interpretation, including single-gene and chromosomal disorders.
The workshop also included in-person lab sessions, facilitated Q&As, and application of real-world case studies. This training format facilitating participants to understand the strict methodologies required for correct interpretation of genetic variants.
The workshop provided an in-depth review of American College of Medical Genetics (ACMG) guidelines for variant classification and interpretation, and provided participants with hands-on experience in variant classification, database tool application, and interpretation workflow.
The course focused on critical thinking and inquisitiveness, challenging participants to ask, to deconstruct, and situate patient cases, disease phenotypes, and patterns of familial inheritance. Professional backgrounds varied among learners and enriched classroom discussion, with jarring juxtapositions of case studies highlighting the nuance and intricacy of interpreting genetic disease.
After the on-campus program, participants have subsequently shifted to a hybrid "offline + online" model in order to proceed with their learning. The last certification process is in process, facilitated by BGI Genomics' digital platforms and mentorship.
" BilimLIBINTWe are pleased to be a platform for international cooperation and capacity development in clinical genomics", said Jeremy Cao, General Manager of BGI Genomics Southeast Asia. "We eagerly look forward to cultivating long-term collaborations and promoting genetic disease diagnosis in Southeast Asia".
This seminar is a demonstration of BGI Genomics' continued dedication to international education, medical technology innovation, and cross-border knowledge sharing. Additional regional training programs are planned as the company increases its investment in the development of genetic healthcare around the world.
